Redeye provides its initial comments on BICO following its Q3 results, which came in above expectations overall. However, the company also announced an impairment of cSEK1bn, relating to Discover ECHO and Biosero. Despite this, the report was well received by the market, with the stock rising by double digits.
LÄS MER
